Invokana Diabetes Drug

ATTENTION: HEALTH WARNING

This is an important health alert for anyone being treated for Type 2 Diabetes.

If you have type 2 diabetes and take Invokana, please read this for very important information about serious health risks:

Invokana – How It Works

The drug Invokana was launched in the spring of 2013, and by early 2015 annual sales were projected to exceed $1.2 billion. designed to work with the patient’s kidneys to help remove sugar from the body through the process of urination. By design it allows high levels of glucose to enter the kidneys. It triggers the body’s emergency process to jettison the excess sugar via urinary excretion.

Invokana – What Happens To Your Body

Normal bodies produce insulin which metabolizes sugar so it can be used as an energy for the body. When there isn’t enough insulin to complete this task, the body cannibalizes fat as an alternative energy source. When that happens, it produces a high level of blood acids called ketones, and this buildup causes a condition called diabetic ketoacidosis (DKA). Type 1 diabetics take insulin to prevent DKA, a condition which has a very high risk of causing a heart attack.

Invokana – The Problem

By allowing the buildup of sugar in the kidneys without the introduction of additional insulin (either naturally produced by the body or taken as medication), Invokana actually decreases urinary excretion of ketones. DKA is now appearing in Invokana patients with normal or near normal glucose counts. While Invokana is working as predicted in terms of glucose, it is also causing a very dangerous elevation of ketones levels in the blood: DKA, a serious condition which may require either hospitalization or emergency room care.

Invokana – The Risk: Heart Attack

Studies have shown in the first 30 days of use, patients who were taking Invokana had a 690% higher likelihood of suffering a cardiovascular event (heart attack) than patients who were taking a placebo.

Invokana – The Risk: Amputations

Findings from two large clinical studies indicate there is an increased risk of leg and foot amputation in type 2 diabetes patients.  The FDA to required an update in the boxed warning to indicate this increased risk in amputation.

What should you do if you are currently taking Invokana or another drug in this class?

Don’t stop taking Invokana or any prescribed medication without consulting with your doctor, but do be sure to consult carefully with your physician and ask about alternative treatment options. If you or a loved one has suffered any cardiac problems while taking Invokana, please call for legal advice right away. You can reach us day or night at 1-888-Steve-Ruth (1-888-783-8378).

Please seek immediate medical assistance if you experience any of the following symptoms:

  • Difficulty Breathing
  • Nausea
  • Vomiting
  • Abdominal Pain
  • Confusion
  • Unusual Fatigue or Sleepiness
  • Sore or ulcers
  • Infection in legs or feet

The FDA (US Food & Drug Administration) has issued a safety announcement about Invokana, which is part of a class of medications called SGLT2 inhibitors. This warning was made because there have been a significant number of adverse effects reported.

“FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood.”

In addition to the danger of serious cardiac problems, the Institute of Safe Medication Practices (ISMP) has also issued a warning specifically about Invokana. In that report, no fewer than 457 reports of serious adverse events related to kidney complications from Invokana were identified during the initial year the drug was on the market. Specifically, Invokana problems involved dehydration, kidney failure, kidney impairment or problems with kidney stones, hypersensitivity, urinary tract infections, and abnormal weight loss.

While the FDA has yet to order a general recall of these products, doctors and lawyers across the country have begun to suggest the detrimental effects of SGLT 2 inhibitors may pose a greater risk than the type 2 diabetes they’re meant to treat. Even though the FDA has not recalled the drugs and initially gave them its approval, claims by people injured by this class of drug may not be prevented. We are investigating whether or not the makers knew or should have known of the danger the drug posed to the people using it.  While any litigation may take years and millions of dollars to complete, the payouts are generally quite significant and often result in the cessation of the sale and production of drugs proven to be more dangerous than helpful, thus improving the overall quality of the U.S. drug market.

A List of SGLT 2 Drugs:

Drug Name Active Ingredient
Invokana canagliflozin
Invokamet canagliflozin & metformin
Farxiga dapagliflozin
Xigduo XR dapagliflozin & metformin extended release
Jardiance empagliflozin
Glyxambi empagliflozin & linagliptin

The Ruth Law Team has extensive experience representing victims of dangerous drug side effects and obtaining financial compensation from the responsible pharmaceutical corporations. If you’d like to obtain more information or ask any questions, please feel free to call our firm and speak directly with one of our attorneys who will be happy to help you with this serious matter. There is never a fee to speak with our attorneys.

You can call us any time at 1-888-783-8378. Let the lawyers of The Ruth Law Team help you Get Justice.